Skip to Content

INV 314 7.5 (Warfarin Sodium 7.5 mg)

Pill with imprint INV 314 7.5 is Yellow, Four-sided and has been identified as Warfarin Sodium 7.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Warfarin is used in the treatment of prevention of thromboembolism in atrial fibrillation; antiphospholipid syndrome; deep vein thrombosis, first event; deep vein thrombosis prophylaxis after hip replacement surgery; chronic central venous catheterization (and more), and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Warfarin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INV 314 7.5

Warfarin Sodium

INV 314 7.5
7.5 mg
Prescription only
Drug Class:
Coumarins and indandiones
Pregnancy Category:
D - Positive evidence of risk - for women with mechanical heart valves
X - Not for use in pregnancy - for other pregnant populations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.